Verastem, Inc. (VSTM)
NASDAQ·Healthcare·Biotechnology
$5.46
-1.53%
Mkt Cap $409.64M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 4, 2026 | $16.90M | $17.54M | +3.73% | -$0.49 | -$0.39 | +20.41% | — | — |
| Q4 2025 Nov 4, 2025 | $16.53M | $11.24M | -31.99% | -$0.51 | -$1.35 | -164.71% | — | — |
| Q3 2025 Aug 7, 2025 | $5.70M | $2.14M | -62.49% | -$0.85 | -$0.39 | +54.12% | — | — |
| Q2 2025 May 13, 2025 | $100.00K | — | — | -$0.72 | -$0.96 | -33.33% | — | — |
| Q1 2025 Mar 20, 2025 | $150.00K | $9.98M | +6550.67% | -$0.81 | -$1.33 | -64.20% | — | — |
| Q4 2024 Nov 6, 2024 | $133.33K | — | — | -$0.71 | -$0.60 | +15.49% | — | — |
| Q3 2024 Aug 8, 2024 | $50.00K | $10.00M | +19900.00% | -$1.06 | -$0.31 | +70.75% | — | — |
| Q2 2024 May 9, 2024 | — | — | — | -$1.16 | -$1.26 | -8.62% | — | — |
| Q1 2024 Mar 14, 2024 | $5.09M | $114.00K | -97.76% | -$0.82 | -$1.02 | -24.39% | — | — |
| Q4 2023 Nov 8, 2023 | $5.09M | — | — | -$0.92 | -$0.75 | +18.48% | — | — |
| Q3 2023 Aug 8, 2023 | $20.00K | — | — | -$1.13 | -$1.37 | -21.24% | — | — |
| Q2 2023 May 9, 2023 | $20.00K | — | — | -$1.08 | -$0.96 | +11.11% | — | — |
| Q1 2023 Mar 14, 2023 | — | $2.60M | — | $0.10 | -$0.96 | -1060.00% | — | — |
| Q4 2022 Nov 3, 2022 | — | — | — | -$1.44 | -$1.08 | +25.00% | — | — |
| Q3 2022 Aug 8, 2022 | — | — | — | -$1.32 | -$1.44 | -9.09% | — | — |
| Q2 2022 May 9, 2022 | $1.50M | $2.60M | +73.07% | -$0.96 | -$1.08 | -12.50% | — | — |
| Q1 2022 Mar 28, 2022 | $50.00K | $545.00K | +990.00% | -$0.96 | -$1.08 | -12.50% | — | — |
| Q4 2021 Nov 4, 2021 | $1.83K | $2.00K | +9.11% | -$1.08 | -$1.56 | -44.44% | — | — |
| Q3 2021 Aug 2, 2021 | $50.00K | $500.00K | +900.00% | -$1.08 | -$1.20 | -11.11% | — | — |
| Q2 2021 May 11, 2021 | $1.01M | $1.01M | +0.00% | -$1.08 | -$1.08 | +0.00% | — | — |